Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Panminerva Med ; 45(2): 123-31, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12855937

ABSTRACT

The numerous risk factors for acute cerebrocardiovascular events present in postmenopausal women have attracted a multidisciplinary approach. In hypertensive patients and postmenopausal intensive alike, the need for stratification of risk based on blood pressure, association of other risk factors and organ damage is becoming more and more evident. This study investigated some emerging factors, such as endothelial dysfunction, adhesion molecules and elevated homocysteine levels that may be markers of organ damage. It also examined the current importance of carotid US intima-media thickness assessment, cardiac US imaging and 24 hour ambulatory blood pressure monitoring (ABPM) in detecting organ damage. The study results indicated that the conventional stratification of cerebrocardiovascular risk in these patients is changing. The new approach in postmenopausal hypertensives tends to assess the presence of other emerging factors. Furthermore, assessment of organ damage is crucial for determining disease development and outcome that may be positively influenced by suitable pharmacological treatment.


Subject(s)
Cardiovascular Diseases/etiology , Cerebrovascular Disorders/etiology , Hypertension/complications , Postmenopause , Blood Pressure , Blood Vessels/diagnostic imaging , Echocardiography , Endothelium, Vascular/physiopathology , Female , Humans , Hypertension/diagnostic imaging , Hypertension/physiopathology , Risk Factors
2.
Clin Ter ; 154(6): 391-4, 2003.
Article in Italian | MEDLINE | ID: mdl-14994518

ABSTRACT

Circulatory effects of parathyroid hormone (PTH) were reported in experimental animal models, also in liver portal system. We devised to study non invasively relationship between plasmatic iPTH and portal blood flow rate in humans. The study was done in a group of healthy post-menopausal women aged 52.0 +/- 5.2 years (range 47-65), not treated with hormone therapy, with different body mass index. Women were studied by echocolor-doppler and by clinical and biochemical assays of common laboratory test and of iPTH, insulin and prolactin (RIA). A positive correlation between iPTH and mean portal flow rate was observed in the overall group. Women with BMI < 25 showed a more marked correlation between these two parameters, not observed in women with BMI > 25, with slight-moderate overweight. In this last group an inverse correlation between blood pressure and iPTH was observed. From these preliminary results, as previously observed in chronic disease, relationship among iPTH, regional flows and nutritional state can be operating also in physiological conditions.


Subject(s)
Liver Circulation/physiology , Nutritional Status , Parathyroid Hormone/physiology , Portal System/physiology , Aged , Blood Flow Velocity , Female , Humans , Middle Aged
3.
Clin Ter ; 152(4): 235-40, 2001.
Article in Italian | MEDLINE | ID: mdl-11725615

ABSTRACT

Psychophysiological relationship in menopausal women was explored by the comparison of stress level and resistance to stress and related symptoms: socio-economic and cultural variables and willingness to participate into a specific therapeutic program were taken into account. One hundred women, aged 44-59 years (54.2 +/- 5.64), that consecutively were referred to an out-patient menopausal Clinic, were studied by a questionnaire that evaluates quality of life (qol) derived and adapted from the Sickness Impact Profile and the Functional Living Test; moreover the test MSP (psychological stress measurement), translated from the original and adapted to Italy, was used. Psychological complaints of women examined are minimal: adaptation tests are substantially normal, and stress index measurements are even lower in comparison with a gender and age matched population group. Our results suggest that after a short period of psychological tension at the onset of climaterium, women acquire a positive, stable status, well different from stereotypes and prejudices around psychological disturbance associated with menopause. Minimal relevance of perceived disturbance seems the reason that limits the women's need and request for a specific therapy. Menopausal depression seems more related to life changes than to hormonal alterations. Reduced physical fitness, increased risk of parental death, difficulty to cope with new roles, apart the care of adult sons or daughters. A critical point is socio-economic level and the possibility to maintain a satisfying work. Contextual conditions, and specially degree of instruction, type of role change inside the family and number of sons, appears the most evident and relevant variables that mediate psychophysical conditions and perceived quality of life.


Subject(s)
Menopause , Quality of Life , Adult , Female , Humans , Middle Aged
4.
J Endocrinol Invest ; 24(6): 423-9, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11434666

ABSTRACT

Bone loss following menopause can be prevented or reduced by estrogen replacement therapy (ERT). The primary action of estrogen on bone is generally considered to be antiresorptive, but some evidence would also suggest a stimulatory effect on bone formation. The aim of this study was to assess the effect of ERT on biochemical markers of bone resorption (urinary pyridinoline and deoxypyridinoline), and of bone formation (bone-specific alkaline phosphatase--B-ALP, and the C-terminal propeptide of type I collagen--CICP) in a group of 25 postmenopausal women with no evidence of osteoporosis. Since the suggested anabolic effect of estrogen seems to take place in the early period of ERT, we measured the response of markers immediately before and after the start of treatment (30, 60, 120 and 180 days). The markers of bone resorption started to decrease at 30 days and remained low thereafter. We also observed a similar decrease in serum levels of B-ALP and CICP, reflecting a reduction of bone formation rate. Our data would indicate that ERT at the given dose does not have early anabolic effects on bone, in addition to its recognized suppressive effect on bone resorption.


Subject(s)
Biomarkers/analysis , Bone Remodeling , Estrogen Replacement Therapy , Postmenopause , Alkaline Phosphatase/blood , Amino Acids/urine , Bone Density , Bone and Bones/enzymology , Female , Humans , Interleukin-6/blood , Middle Aged , Peptide Fragments/blood , Procollagen/blood , Transforming Growth Factor beta/blood
5.
Climacteric ; 3(4): 241-7, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11910583

ABSTRACT

OBJECTIVE: The aim of this analysis is to find any association between the use of hormone replacement therapy (HRT) and sociodemographic and clinical factors among women attending 54 menopause clinics in Italy. METHODS: The analysis includes data relating to 17,851 women who attended one of 54 menopause clinics in Italy for general gynecological evaluations and counselling between 1995 and 1997. The characteristics of women reporting ever HRT use were compared with those of never users. The odds ratios (ORs) of HRT use were computed in relation to selected reference categories, together with their 95% confidence intervals (CIs). RESULTS: Of the 17,851 women interviewed, 8539 reported ever HRT use. The mean age of the never and ever HRT users was 52.8 years and 53.7 years, respectively. Higher education was associated with an increased frequency of HRT use: in comparison with women reporting no or primary-/middle-school education, the OR of HRT use of women reporting a high-school diploma or university degree was 1.3 (95% CI 1.1-1.6). HRT use tended to be less frequently reported with increasing body mass index (BMI): in comparison with women whose BMI was < 23.4 kg/m2, the OR of HRT use in those with a BMI of 23.4-26.1 kg/m2 and > or = 26.2 kg/m2 was 0.8 (95% CI 0.8-0.9) and 0.6 (95% CI 0.5-0.7), respectively. Among the postmenopausal women, those who had undergone surgical menopause had an OR of HRT use of 1.3 (95% CI 1.2-1.4). A history of breast cancer was associated with a lower frequency of HRT use (OR 0.3, 95% CI 0.2-0.4). Likewise, a history of thromboembolic disease (OR 0.5, 95% CI 0.4-0.7) or myocardial infarction (OR 0.7, 95% CI 0.6-0.9) was associated with a lower frequency of HRT use. CONCLUSIONS: In our study population, the variable most closely related to HRT use was education/social class, thus underlining the impact of information campaigns on HRT and women's health. Among the medical determinants, our analysis indicates that a history of myocardial infarction, thromboembolic disease or breast cancer is associated with less frequent use of HRT.


Subject(s)
Hormone Replacement Therapy/statistics & numerical data , Menopause , Patient Acceptance of Health Care/statistics & numerical data , Adult , Age Factors , Aged , Body Mass Index , Female , Humans , Interviews as Topic , Italy/epidemiology , Middle Aged , Outpatient Clinics, Hospital , Prospective Studies , Socioeconomic Factors , Women's Health
6.
Eur Rev Med Pharmacol Sci ; 4(1-2): 25-30, 2000.
Article in English | MEDLINE | ID: mdl-11409186

ABSTRACT

Changes in the metabolic hormonal balance during the climacteric and menopause, especially surgically induced menopause, increase the risk of acute cerebrocardiovascular complications. This major risk may be linked to changes in blood pressure. In this study we performed twenty-four ambulatory blood pressure monitoring in climacteric (C), menopausal (PM), and surgically induced menopausal women (SM) to determine mean diurnal and nocturnal systodiastolic levels and percentage peaks, as variations in the pressure profile may be linked to organ damage. Our results showed that the entire series presented mainly diastolic increments (mDBP: HPM = 104.4 +/- 5.1; HSM = 106.3 +/- 2.9; HC = 100.2 +/- 3.1), and that this rise was greater in surgically induced menopausal women. In addition, these subjects presented the highest diastolic and systolic pressure peaks (HSM 37/42 versus HPM 35/36 and HC 29/31) also during the night (nocturnal peak: HSM 15/19 versus HPM 10/12 and HC 5/15). Non dippers seem more exposed to cerebrocardiovascular disease. Our results revealed that climacteric patients affected by arterial hypertension (mSBP = 162.2 +/- 4.1; mDBP = 100.2 +/- 3.1; 24 h systolic peak % = 24, diastolic peak % = 24) during the climacteric presented the same levels as observed in conclaimed menopause (mSBP 165.2 +/- 5.5; mDBP = 104.2 +/- 5.1; 24 h systolic peak % = 28, diastolic peak % = 29). Therefore, 24 h blood pressure monitoring is able to show that the pressure changes in hypertensive climacteric and menopausal women and could detect women who are at a greater risk of organ damage.


Subject(s)
Blood Pressure Monitoring, Ambulatory , Blood Pressure/physiology , Climacteric/physiology , Menopause/physiology , Adult , Female , Humans , Middle Aged , Reference Values
SELECTION OF CITATIONS
SEARCH DETAIL
...